Myelodysplastic SyndromesLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemiaLeukemia, MyeloidAnemia, Refractory, with Excess of BlastsCytarabineAnemia, RefractoryBlast CrisisBone MarrowSyndromeLeukemia, Myelomonocytic, ChronicKaryotypingDaunorubicinRemission InductionFusion Proteins, bcr-ablChromosome AberrationsAcute DiseaseCore Binding Factor Alpha 2 SubunitChromosomes, Human, Pair 5AzacitidineBone Marrow TransplantationK562 CellsPreleukemiaBenzamidesAntineoplastic AgentsTransplantation, HomologousMyeloproliferative DisordersHematopoietic Stem CellsPiperazinesChromosomes, Human, Pair 21MonosomyCytogenetic AnalysisPrecursor Cell Lymphoblastic Leukemia-LymphomaPrognosisTranslocation, Geneticfms-Like Tyrosine Kinase 3Hematopoietic Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeGene Expression Regulation, LeukemicBone Marrow CellsPyrimidinesHL-60 CellsLeukemia, LymphoidLeukemia, Myelomonocytic, AcuteNeoplasms, Second PrimaryIdarubicinChromosomes, Human, Pair 8Chromosomes, Human, 21-22 and YThioguanineChromosomes, Human, Pair 7Anemia, SideroblasticArabinofuranosylcytosine TriphosphateRecurrencePhiladelphia ChromosomeVidarabineSurvival AnalysisAnemia, AplasticNeoplastic Stem CellsAntigens, CD34Leukemia, Lymphocytic, Chronic, B-CellMitoxantroneAntimetabolites, AntineoplasticTumor Cells, CulturedOncogene Proteins, FusionLeukemia, Myeloid, Chronic-PhaseThalidomideSurvival RateTransplantation ConditioningHematopoiesisGranulocyte Colony-Stimulating FactorGraft vs Host DiseaseGranulocytesGranulocyte Precursor CellsFlow CytometryApoptosisSialic Acid Binding Ig-like Lectin 3Bone Marrow DiseasesLeukemia, Myeloid, Chronic, Atypical, BCR-ABL NegativeLeukemia, ExperimentalMutationSarcoma, MyeloidCytogeneticsChromosome DisordersLeukemia, Monocytic, AcuteMyelodysplastic-Myeloproliferative DiseasesTransplantation, AutologousHematologic NeoplasmsBusulfan